🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06074770
Recruiting Observational

Study on Dietary Intake Levels of Iodine for 3-6 Years Old Pre-school Children

NCT06074770 · tracked via the Priya Life Science China tracker
Sponsor
Chen Wen
Phase
Observational
Started
2023-05-05
Last updated
2023-10-10

Condition(s) studied

Nutritional Requirements

Investigational drug(s) / intervention(s)

no intervention

no intervention: Natural exposure of iodine

Study summary

Iodine as an essential trace element for human, both excessive and insufficient intake would be harmful for human health. As susceptible population, children will be more sensitive to adverse effects caused by inadequate intake of iodine since they are at the peak of growth and development. Meanwhile, there are few direct evidence to establish dietary intakes levels of iodine for 3-6 years old pre-school children.

Eligibility

Sex
ALL
Min age
3 Years
Max age
6 Years
Healthy volunteers
Accepted
Inclusion Criteria: * for children with mild malnutrition: hemoglobin \<110g / L, or weight for age \<P50 according to the Chinese 2009 child growth and development reference standard, or BMI z score \<-1 according to the WHO Child Growth Assessment Software (version 3.2.2 ) ; have not been treated for thyroid disease; have not used amiodarone and other drugs (including iodine supplements) during the investigation; have no major diseases ,chronic diseases and family history. * for children with good nutritional status: healthy,-1 \<BMI z score \<1; have not been treated for thyroid disease; have not used amiodarone and other drugs (including iodine supplements) during the investigation; have no major diseases ,chronic diseases and family history; Exclusion Criteria: long-term low-protein; long-term low-heat energy malnutrition

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shandong Institute for Endemic Disease Control and Research Yuncheng Shandong Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06074770 on ClinicalTrials.gov ↗ ← All trials in China